Electromed (ELMD) Stock Price

Electromed Price

NYSE AMEX·CLOSED
28.20
​
Market closed

Revenue has compounded at 12.6% per year over the past 18 years to 73.78 M USD. Earnings per share have grown at 21.1% per year over the last 18 years. Electromed's net margin stands at 15.3%, up from 5.5% several years earlier. Analysts set a median price target of 37.00 USD, implying 31.2% above the current price. Of 8 analysts, 7 rate the stock a buy — an overall Buy consensus.

Electromed stock price

Access this data via the Eulerpool API

Electromed business model & stock analysis

Electromed, Inc. engages in the development, manufacture, marketing, and sale of medical equipment. The company is headquartered in New Prague, Minnesota and currently employs 170 full-time employees. The company went IPO on 2010-08-13. The firm applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. Its SmartVest Connect wireless technology is a personalized HFCWO therapy management portal for patients with compromised pulmonary function. The SmartVest Connect app securely connects to the SmartVest System through Bluetooth technology. The firm also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.

Frequently asked questions about Electromed

Analysts currently set an average price target of 37.00 USD for the Electromed stock (median: 37.00 USD), implying +31.2 % versus the latest price. The consensus is based on 8 analyst ratings.

8 analysts currently rate the Electromed stock: 7 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the Electromed share trades at 25.18 EUR (28.20 USD).

The revenue of Electromed is 73.78 M USD. This figure is based on current financial data and reflects the company's business performance.

The profit of Electromed is 11.30 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Electromed is currently 21.68. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Electromed stock.

The price-to-sales ratio (P/S) of Electromed is currently 3.32. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Electromed stock.

The Eulerpool Quality Score for Electromed is 8/10.

The ISIN of Electromed is US2854091087. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Electromed is ELMD. The ticker symbol is used to trade Electromed shares on the stock exchange.

Fair ValueTerminal
24.25 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
416,813.56 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
Aug 13, 2010
ISIN
US2854091087
Cusip
285409108
Market capitalization
235.19 M USDMicro Cap
52-Week Range
PEG
-3.80
P/E ratio
P/Ee 2027
19.38
P/Ee 2028
16.69
P/Ee 2029
13.49
P/Ee 2030
24.52
P/S
P/Se
2.95
EV/EBIT
15.47
P/B Ratio
4.36
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
20.91 %
Last updated Oct 8, 2026, 5:22 PM

Electromed Peer Group

Electromed Ticker

AMEX · ELMD

Electromed FIGI

ELMD:US · BBG000QN5ZH9ELMD:UA · BBG000QN5ZW2ELMD:UC · BBG000QN60B1ELMD:UN · BBG000QN61C8ELMD:UP · BBG000QN61P4ELMD:UB · BBG000QN62D5ELMD:UT · BBG000QN63Q9ELMD:UM · BBG000QN63W2ELMD:UX · BBG000QN6423ELMD:UD · BBG000QN65R3ELMD:UF · BBG000QN67N3ELMD:VY · BBG000QN6806

All fundamentals and in-depth analysis of Electromed

Our stock analysis for Electromed stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Electromed. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.